BMY vs JNJ: Side-by-Side Comparison
Compare Bristol-Myers Squibb Company (BMY) and Johnson & Johnson (JNJ) side by side: market cap USD 118.71B vs USD 633.19B, P/E 16.3 vs 30.4. Financials, growth and model signals on Bullrun.
| Metric | BMY | JNJ |
|---|---|---|
| Company | Bristol-Myers Squibb Company | Johnson & Johnson |
| Country / Exchange | United States · NYSE | United States · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 118.71B | USD 633.19B |
| P/E ratio | 16.3 | 30.4 |
| Dividend yield | 5.38% | 1.99% |
| Valuation model | 21.4% undervalued | 3.0% undervalued |
| Revenue (FY2025) | USD 48.19B | USD 94.19B |
| Revenue growth YoY | -0.2% | +6.0% |
| Net income | USD 7.05B | USD 26.80B |
| Gross margin | 71.1% | 67.9% |
| Diluted EPS | 3.46 | 11.03 |